Thought Leadership

This whitepaper explores the hype versus the current reality for AI technologies within pharmacovigilance and examines the main business use cases today plus the potential gains for biopharmaceutical safety teams. We provide a decision guide to help assess whether an AI approach is appropriate, or whether more established methods with demonstrated benefits – such as rules-based automation – are better suited for the job at hand.